O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos

AUTOR(ES)

Marinho, Vera Maria Costa, Seidl, Peter Rudolf, Longo, Waldimir Pirró e

FONTE

Química Nova

DATA DE PUBLICAÇÃO

2008

RESUMO

The importance of natural products as a source of new high value-added drugs has, no doubt, transformed Brazilian megadiversity into one of the country's most valuable and strategic assets. Thus the rational exploration of the Brazilian flora on an economic basis should be considered as part of a national development strategy. In this respect, governmental mechanisms to stimulate regulation on the access, bioprospection and industrial use of natural products represent a crucial issue. The aim of this paper is to show how the incentives and institutional arrangements that led to one of the greatest breakthroughs in the pharmaceutical industry, the development and commercialization of the anti-cancer agent Taxol, could be applied to the Brazilian case.

Documentos Relacionados

• Fatores críticos na implementação da Norma NBR ISO/IEC 17025: estudo de caso de um laboratório de P&D governamental
• Da P&D à inovação: desafios para o setor elétrico brasileiro
• Internacionalização da P&D
• P&D versus inovação
• Complementaridade entre a P&D Interna e a Cooperação em P&D no Contexto das Oportunidades Tecnológicas Espanholas